APO Research
Talk to an analyst

APO RESEARCH · REPORT

Microbial Alternative Protein

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Microbial Alternative Protein Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

13 August 2026188 pages

Choose your research edition.

Industry ResearchMicrobial Alternative Protein Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Microbial Alternative Protein Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Microbial Alternative Protein Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Microbial Alternative Protein Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Microbial Alternative Protein Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Microbial Alternative Protein market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Microbial Alternative Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Microbial Alternative Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Microbial Alternative Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Microbial Alternative Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Microbial Alternative Protein include AgriProtein (South Africa), Ynsect (France), Enterra Feed Corporation (Canada), Protix (The Netherlands), Proti-Farm Holding NV (The Netherlands), Entomo Farms (Canada), Global Bugs Asia Co., Ltd. (Thailand), Aspire Food Group (U.S.) and Tiny Farms (U.S.), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Microbial Alternative Protein market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Microbial Alternative Protein and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Microbial Alternative Protein sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Microbial Alternative Protein market size, projected growth trends, production technologies, key applications, and end-use industries.

Microbial Alternative Protein Segment by Company

AgriProtein (South Africa)

Ynsect (France)

Enterra Feed Corporation (Canada)

Protix (The Netherlands)

Proti-Farm Holding NV (The Netherlands)

Entomo Farms (Canada)

Global Bugs Asia Co., Ltd. (Thailand)

Aspire Food Group (U.S.)

Tiny Farms (U.S.)

Microbial Alternative Protein Segment by Type

Yeast Protein

Microalgae Protein

Bacterial Protein

Other

Microbial Alternative Protein Segment by Application

Food

Feed

Others

Microbial Alternative Protein Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microbial Alternative Protein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Microbial Alternative Protein and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microbial Alternative Protein.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Microbial Alternative Protein market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Microbial Alternative Protein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Microbial Alternative Protein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Microbial Alternative Protein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Microbial Alternative Protein Industry Trends Table 2. Microbial Alternative Protein Industry Drivers Table 3. Microbial Alternative Protein Industry Opportunities and Challenges Table 4. Microbial Alternative Protein Industry Restraints Table 5. Global Microbial Alternative Protein Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Microbial Alternative Protein Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Microbial Alternative Protein Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Microbial Alternative Protein Sales Market Share by Manufacturers Table 9. Global Microbial Alternative Protein Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Microbial Alternative Protein Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Microbial Alternative Protein Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Microbial Alternative Protein Manufacturers, Product Type & Application Table 13. Global Microbial Alternative Protein Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Microbial Alternative Protein by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Yeast Protein Table 17. Major Manufacturers of Microalgae Protein Table 18. Major Manufacturers of Bacterial Protein Table 19. Major Manufacturers of Other Table 20. Global Microbial Alternative Protein Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Microbial Alternative Protein Sales by Type (2021-2026) & (k units) Table 22. Global Microbial Alternative Protein Sales by Type (2027-2032) & (k units) Table 23. Global Microbial Alternative Protein Sales Market Share by Type (2021-2026) Table 24. Global Microbial Alternative Protein Sales Market Share by Type (2027-2032) Table 25. Global Microbial Alternative Protein Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Microbial Alternative Protein Revenue by Type (2021-2026) & (k units) Table 27. Global Microbial Alternative Protein Revenue by Type (2027-2032) & (k units) Table 28. Global Microbial Alternative Protein Revenue Market Share by Type (2021-2026) Table 29. Global Microbial Alternative Protein Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Food Table 31. Major Manufacturers of Feed Table 32. Major Manufacturers of Others Table 33. Global Microbial Alternative Protein Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Microbial Alternative Protein Sales by Application (2021-2026) & (k units) Table 35. Global Microbial Alternative Protein Sales by Application (2027-2032) & (k units) Table 36. Global Microbial Alternative Protein Sales Market Share by Application (2021-2026) Table 37. Global Microbial Alternative Protein Sales Market Share by Application (2027-2032) Table 38. Global Microbial Alternative Protein Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Microbial Alternative Protein Revenue by Application (2021-2026) & (k units) Table 40. Global Microbial Alternative Protein Revenue by Application (2027-2032) & (k units) Table 41. Global Microbial Alternative Protein Revenue Market Share by Application (2021-2026) Table 42. Global Microbial Alternative Protein Revenue Market Share by Application (2027-2032) Table 43. Global Microbial Alternative Protein Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Microbial Alternative Protein Sales by Region (2021-2026) & (k units) Table 45. Global Microbial Alternative Protein Sales Market Share by Region (2021-2026) Table 46. Global Microbial Alternative Protein Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Microbial Alternative Protein Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Microbial Alternative Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Microbial Alternative Protein Sales by Country (2021-2026) & (k units) Table 50. North America Microbial Alternative Protein Sales by Country (2027-2032) & (k units) Table 51. Europe Microbial Alternative Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Microbial Alternative Protein Sales by Country (2021-2026) & (k units) Table 53. Europe Microbial Alternative Protein Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Microbial Alternative Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Microbial Alternative Protein Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Microbial Alternative Protein Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Microbial Alternative Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Microbial Alternative Protein Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Microbial Alternative Protein Sales by Country (2027-2032) & (k units) Table 60. Global Microbial Alternative Protein Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Microbial Alternative Protein Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Microbial Alternative Protein Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Microbial Alternative Protein Revenue Market Share by Region (2021-2026) Table 64. Global Microbial Alternative Protein Revenue Market Share by Region (2027-2032) Table 65. AgriProtein (South Africa) Company Information Table 66. AgriProtein (South Africa) Business Overview Table 67. AgriProtein (South Africa) Microbial Alternative Protein Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. AgriProtein (South Africa) Microbial Alternative Protein Product Portfolio Table 69. AgriProtein (South Africa) Recent Development Table 70. Ynsect (France) Company Information Table 71. Ynsect (France) Business Overview Table 72. Ynsect (France) Microbial Alternative Protein Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Ynsect (France) Microbial Alternative Protein Product Portfolio Table 74. Ynsect (France) Recent Development Table 75. Enterra Feed Corporation (Canada) Company Information Table 76. Enterra Feed Corporation (Canada) Business Overview Table 77. Enterra Feed Corporation (Canada) Microbial Alternative Protein Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Enterra Feed Corporation (Canada) Microbial Alternative Protein Product Portfolio Table 79. Enterra Feed Corporation (Canada) Recent Development Table 80. Protix (The Netherlands) Company Information Table 81. Protix (The Netherlands) Business Overview Table 82. Protix (The Netherlands) Microbial Alternative Protein Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Protix (The Netherlands) Microbial Alternative Protein Product Portfolio Table 84. Protix (The Netherlands) Recent Development Table 85. Proti-Farm Holding NV (The Netherlands) Company Information Table 86. Proti-Farm Holding NV (The Netherlands) Business Overview Table 87. Proti-Farm Holding NV (The Netherlands) Microbial Alternative Protein Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Proti-Farm Holding NV (The Netherlands) Microbial Alternative Protein Product Portfolio Table 89. Proti-Farm Holding NV (The Netherlands) Recent Development Table 90. Entomo Farms (Canada) Company Information Table 91. Entomo Farms (Canada) Business Overview Table 92. Entomo Farms (Canada) Microbial Alternative Protein Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Entomo Farms (Canada) Microbial Alternative Protein Product Portfolio Table 94. Entomo Farms (Canada) Recent Development Table 95. Global Bugs Asia Co., Ltd. (Thailand) Company Information Table 96. Global Bugs Asia Co., Ltd. (Thailand) Business Overview Table 97. Global Bugs Asia Co., Ltd. (Thailand) Microbial Alternative Protein Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Global Bugs Asia Co., Ltd. (Thailand) Microbial Alternative Protein Product Portfolio Table 99. Global Bugs Asia Co., Ltd. (Thailand) Recent Development Table 100. Aspire Food Group (U.S.) Company Information Table 101. Aspire Food Group (U.S.) Business Overview Table 102. Aspire Food Group (U.S.) Microbial Alternative Protein Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Aspire Food Group (U.S.) Microbial Alternative Protein Product Portfolio Table 104. Aspire Food Group (U.S.) Recent Development Table 105. Tiny Farms (U.S.) Company Information Table 106. Tiny Farms (U.S.) Business Overview Table 107. Tiny Farms (U.S.) Microbial Alternative Protein Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Tiny Farms (U.S.) Microbial Alternative Protein Product Portfolio Table 109. Tiny Farms (U.S.) Recent Development Table 110. Key Raw Materials Table 111. Raw Materials Key Suppliers Table 112. Microbial Alternative Protein Distributors List Table 113. Microbial Alternative Protein Customers List Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Microbial Alternative Protein Product Image Figure 2. Global Microbial Alternative Protein Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Microbial Alternative Protein Market Size (2021-2032) & (US$ Million) Figure 4. Global Microbial Alternative Protein Sales (2021-2032) & (k units) Figure 5. Global Microbial Alternative Protein Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Microbial Alternative Protein Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Yeast Protein Image Figure 9. Microalgae Protein Image Figure 10. Bacterial Protein Image Figure 11. Other Image Figure 12. Global Microbial Alternative Protein Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Microbial Alternative Protein Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Microbial Alternative Protein Sales Market Share by Type (2021-2032) Figure 15. Global Microbial Alternative Protein Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Microbial Alternative Protein Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Microbial Alternative Protein Revenue Market Share by Type (2021-2032) Figure 18. Food Image Figure 19. Feed Image Figure 20. Others Image Figure 21. Global Microbial Alternative Protein Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Microbial Alternative Protein Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Microbial Alternative Protein Sales Market Share by Application (2021-2032) Figure 24. Global Microbial Alternative Protein Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Microbial Alternative Protein Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Microbial Alternative Protein Revenue Market Share by Application (2021-2032) Figure 27. North America Microbial Alternative Protein Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Microbial Alternative Protein Sales Market Share by Country (2021-2032) Figure 29. U.S. Microbial Alternative Protein Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Microbial Alternative Protein Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Microbial Alternative Protein Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Microbial Alternative Protein Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Microbial Alternative Protein Sales Market Share by Country (2021-2032) Figure 34. Germany Microbial Alternative Protein Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Microbial Alternative Protein Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Microbial Alternative Protein Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Microbial Alternative Protein Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Microbial Alternative Protein Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Microbial Alternative Protein Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Microbial Alternative Protein Sales Market Share by Country (2021-2032) Figure 41. China Microbial Alternative Protein Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Microbial Alternative Protein Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Microbial Alternative Protein Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Microbial Alternative Protein Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Microbial Alternative Protein Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Microbial Alternative Protein Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Microbial Alternative Protein Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Microbial Alternative Protein Sales Market Share by Country (2021-2032) Figure 49. Brazil Microbial Alternative Protein Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Microbial Alternative Protein Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Microbial Alternative Protein Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Microbial Alternative Protein Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Microbial Alternative Protein Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Microbial Alternative Protein Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Microbial Alternative Protein Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Microbial Alternative Protein Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Microbial Alternative Protein Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Microbial Alternative Protein Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Microbial Alternative Protein Revenue (2021-2032) & (US$ Million) Figure 60. North America Microbial Alternative Protein Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Microbial Alternative Protein Revenue (2021-2032) & (US$ Million) Figure 62. Europe Microbial Alternative Protein Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Microbial Alternative Protein Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Microbial Alternative Protein Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Microbial Alternative Protein Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Microbial Alternative Protein Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Microbial Alternative Protein Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Microbial Alternative Protein Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Yeast Protein
  • Microalgae Protein
  • Bacterial Protein
  • Other
Applications
  • Food
  • Feed
  • Others
Companies covered
  • AgriProtein (South Africa)
  • Ynsect (France)
  • Enterra Feed Corporation (Canada)
  • Protix (The Netherlands)
  • Proti-Farm Holding NV (The Netherlands)
  • Entomo Farms (Canada)
  • Global Bugs Asia Co., Ltd. (Thailand)
  • Aspire Food Group (U.S.)
  • Tiny Farms (U.S.)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Microbial Alternative Protein Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Microbial Alternative Protein Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Microbial Alternative Protein Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Microbial Alternative Protein Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Microbial Alternative Protein Market Dynamics
  1. 2.1 Microbial Alternative Protein Industry Trends
  2. 2.2 Microbial Alternative Protein Industry Drivers
  3. 2.3 Microbial Alternative Protein Industry Opportunities and Challenges
  4. 2.4 Microbial Alternative Protein Industry Restraints
3 Microbial Alternative Protein Market by Manufacturers
  1. 3.1 Global Microbial Alternative Protein Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Microbial Alternative Protein Sales by Manufacturers (2021-2026)
  3. 3.3 Global Microbial Alternative Protein Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Microbial Alternative Protein Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Microbial Alternative Protein Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Microbial Alternative Protein Manufacturers, Product Type & Application
  7. 3.7 Global Microbial Alternative Protein Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Microbial Alternative Protein Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Microbial Alternative Protein Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Microbial Alternative Protein Tier 1, Tier 2, and Tier 3
4 Microbial Alternative Protein Market by Type
  1. 4.1 Microbial Alternative Protein Type Introduction
  2. 4.1.1 Yeast Protein
  3. 4.1.2 Microalgae Protein
  4. 4.1.3 Bacterial Protein
  5. 4.1.4 Other
  6. 4.2 Global Microbial Alternative Protein Sales by Type
  7. 4.2.1 Global Microbial Alternative Protein Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Microbial Alternative Protein Sales by Type (2021-2032)
  9. 4.2.3 Global Microbial Alternative Protein Sales Market Share by Type (2021-2032)
  10. 4.3 Global Microbial Alternative Protein Revenue by Type
  11. 4.3.1 Global Microbial Alternative Protein Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Microbial Alternative Protein Revenue by Type (2021-2032)
  13. 4.3.3 Global Microbial Alternative Protein Revenue Market Share by Type (2021-2032)
5 Microbial Alternative Protein Market by Application
  1. 5.1 Microbial Alternative Protein Application Introduction
  2. 5.1.1 Food
  3. 5.1.2 Feed
  4. 5.1.3 Others
  5. 5.2 Global Microbial Alternative Protein Sales by Application
  6. 5.2.1 Global Microbial Alternative Protein Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Microbial Alternative Protein Sales by Application (2021-2032)
  8. 5.2.3 Global Microbial Alternative Protein Sales Market Share by Application (2021-2032)
  9. 5.3 Global Microbial Alternative Protein Revenue by Application
  10. 5.3.1 Global Microbial Alternative Protein Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Microbial Alternative Protein Revenue by Application (2021-2032)
  12. 5.3.3 Global Microbial Alternative Protein Revenue Market Share by Application (2021-2032)
6 Global Microbial Alternative Protein Sales by Region
  1. 6.1 Global Microbial Alternative Protein Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Microbial Alternative Protein Sales by Region (2021-2032)
  3. 6.2.1 Global Microbial Alternative Protein Sales by Region (2021-2026)
  4. 6.2.2 Global Microbial Alternative Protein Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Microbial Alternative Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Microbial Alternative Protein Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Microbial Alternative Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Microbial Alternative Protein Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Microbial Alternative Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Microbial Alternative Protein Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Microbial Alternative Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Microbial Alternative Protein Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Microbial Alternative Protein Revenue by Region
  1. 7.1 Global Microbial Alternative Protein Revenue by Region
  2. 7.1.1 Global Microbial Alternative Protein Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Microbial Alternative Protein Revenue by Region (2021-2026)
  4. 7.1.3 Global Microbial Alternative Protein Revenue by Region (2027-2032)
  5. 7.1.4 Global Microbial Alternative Protein Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Microbial Alternative Protein Revenue (2021-2032)
  8. 7.2.2 North America Microbial Alternative Protein Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Microbial Alternative Protein Revenue (2021-2032)
  11. 7.3.2 Europe Microbial Alternative Protein Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Microbial Alternative Protein Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Microbial Alternative Protein Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Microbial Alternative Protein Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Microbial Alternative Protein Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 AgriProtein (South Africa)
  2. 8.1.1 AgriProtein (South Africa) Company Information
  3. 8.1.2 AgriProtein (South Africa) Business Overview
  4. 8.1.3 AgriProtein (South Africa) Microbial Alternative Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AgriProtein (South Africa) Microbial Alternative Protein Product Portfolio
  6. 8.1.5 AgriProtein (South Africa) Recent Developments
  7. 8.2 Ynsect (France)
  8. 8.2.1 Ynsect (France) Company Information
  9. 8.2.2 Ynsect (France) Business Overview
  10. 8.2.3 Ynsect (France) Microbial Alternative Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Ynsect (France) Microbial Alternative Protein Product Portfolio
  12. 8.2.5 Ynsect (France) Recent Developments
  13. 8.3 Enterra Feed Corporation (Canada)
  14. 8.3.1 Enterra Feed Corporation (Canada) Company Information
  15. 8.3.2 Enterra Feed Corporation (Canada) Business Overview
  16. 8.3.3 Enterra Feed Corporation (Canada) Microbial Alternative Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Enterra Feed Corporation (Canada) Microbial Alternative Protein Product Portfolio
  18. 8.3.5 Enterra Feed Corporation (Canada) Recent Developments
  19. 8.4 Protix (The Netherlands)
  20. 8.4.1 Protix (The Netherlands) Company Information
  21. 8.4.2 Protix (The Netherlands) Business Overview
  22. 8.4.3 Protix (The Netherlands) Microbial Alternative Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Protix (The Netherlands) Microbial Alternative Protein Product Portfolio
  24. 8.4.5 Protix (The Netherlands) Recent Developments
  25. 8.5 Proti-Farm Holding NV (The Netherlands)
  26. 8.5.1 Proti-Farm Holding NV (The Netherlands) Company Information
  27. 8.5.2 Proti-Farm Holding NV (The Netherlands) Business Overview
  28. 8.5.3 Proti-Farm Holding NV (The Netherlands) Microbial Alternative Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Proti-Farm Holding NV (The Netherlands) Microbial Alternative Protein Product Portfolio
  30. 8.5.5 Proti-Farm Holding NV (The Netherlands) Recent Developments
  31. 8.6 Entomo Farms (Canada)
  32. 8.6.1 Entomo Farms (Canada) Company Information
  33. 8.6.2 Entomo Farms (Canada) Business Overview
  34. 8.6.3 Entomo Farms (Canada) Microbial Alternative Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Entomo Farms (Canada) Microbial Alternative Protein Product Portfolio
  36. 8.6.5 Entomo Farms (Canada) Recent Developments
  37. 8.7 Global Bugs Asia Co., Ltd. (Thailand)
  38. 8.7.1 Global Bugs Asia Co., Ltd. (Thailand) Company Information
  39. 8.7.2 Global Bugs Asia Co., Ltd. (Thailand) Business Overview
  40. 8.7.3 Global Bugs Asia Co., Ltd. (Thailand) Microbial Alternative Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Global Bugs Asia Co., Ltd. (Thailand) Microbial Alternative Protein Product Portfolio
  42. 8.7.5 Global Bugs Asia Co., Ltd. (Thailand) Recent Developments
  43. 8.8 Aspire Food Group (U.S.)
  44. 8.8.1 Aspire Food Group (U.S.) Company Information
  45. 8.8.2 Aspire Food Group (U.S.) Business Overview
  46. 8.8.3 Aspire Food Group (U.S.) Microbial Alternative Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Aspire Food Group (U.S.) Microbial Alternative Protein Product Portfolio
  48. 8.8.5 Aspire Food Group (U.S.) Recent Developments
  49. 8.9 Tiny Farms (U.S.)
  50. 8.9.1 Tiny Farms (U.S.) Company Information
  51. 8.9.2 Tiny Farms (U.S.) Business Overview
  52. 8.9.3 Tiny Farms (U.S.) Microbial Alternative Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Tiny Farms (U.S.) Microbial Alternative Protein Product Portfolio
  54. 8.9.5 Tiny Farms (U.S.) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Microbial Alternative Protein Value Chain Analysis
  2. 9.1.1 Microbial Alternative Protein Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Microbial Alternative Protein Production Mode & Process
  6. 9.2 Microbial Alternative Protein Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Microbial Alternative Protein Distributors
  9. 9.2.3 Microbial Alternative Protein Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst